Some Childhood Cancer Survivors at Higher Risk of Later Obesity

This article originally appeared here.
Share this content:
Some Childhood Cancer Survivors at Higher Risk of Later Obesity
Some Childhood Cancer Survivors at Higher Risk of Later Obesity

(HealthDay News) -- Certain treatments may increase a childhood cancer survivor's risk of obesity later in life, according to research published online May 11 in Cancer.

The researchers looked at 1,996 people who'd been diagnosed with childhood cancer at least 10 years earlier. They found that almost half who underwent cranial radiation were obese. This compared with just over 29 percent of those who did not receive that type of treatment. The risk of obesity among survivors treated with cranial radiation was highest among those who had also received glucocorticoids or who were younger at the time of their cancer diagnosis.

The researchers also found that certain variants of genes involved in neuron growth, repair and connectivity were associated with increased risk of obesity among survivors treated with cranial radiation. Also, survivors who had undergone chest, abdominal, or pelvic radiation were half as likely to be obese as those who did not receive those treatments.

"The ability to identify patients at increased risk may guide selection of therapeutic protocols that will maximize treatment outcomes while simultaneously minimizing the risk of long-term complications among children diagnosed with cancer," study co-leader Kirsten Ness, P.T., Ph.D., of St. Jude Children's Research Hospital in Memphis, Tenn., said in a journal news release.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Social, Communication Delays With False-Negative on M-CHAT

Social, Communication Delays With False-Negative on M-CHAT

Delays for those who pass M-CHAT screening at 18 months but are later diagnosed with ASD

FDA Approves Aimovig to Prevent Migraines

FDA Approves Aimovig to Prevent Migraines

Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo

Risk of Dementia Up for Older Adults With Lowest Wealth

Risk of Dementia Up for Older Adults With ...

Increased risk seen independent of education, index of multiple deprivation, health indicators

is free, fast, and customized just for you!

Already a member?

Sign In Now »